A comparison of outcome for patients undergoing non-myeloablative stem cell transplantation compared to conventional conditioning for multiple myeloma.

被引：0
|
作者：
Hunter, HM
Peggs, K
Powles, R
Apperley, J
Mahendra, P
Cavenagh, J
Littlewood, T
Potter, M
Hunter, A
Pagliuca, A
Williams, C
Cook, G
Towlson, K
Marks, D
Russell, NH
机构：
[1] City Hosp Nottingham, Nottingham, England
[2] UCH, London, England
[3] Royal Marsden Hosp, London SW3 6JJ, England
[4] Hammersmith Hosp, London, England
[5] QEH, Birmingham, W Midlands, England
[6] St Bartholomews & Royal London HOsp, London, England
[7] Oxford Radcliff Hosp, Oxford, England
[8] Royal Free Hosp, London NW3 2QG, England
[9] Leicester Royal Infirm, Leicester, Leics, England
[10] Kings Coll Hosp London, London, England
[11] Christie Hosp & Holt Radium Inst, Manchester M20 9BX, Lancs, England
[12] St James, Leeds, W Yorkshire, England
[13] United Bristol Healthcare Trust, Bristol, Avon, England
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2705
引用
收藏
页码：732A / 732A
页数：1
相关论文
共 50 条
  • [1] Non-myeloablative stem cell transplantation is safe and effective for patients with multiple myeloma.
    Cogle, CR
    Moreb, JS
    Leather, HL
    Wiggins, LE
    Finiewicz, KA
    Khan, SA
    Reddy, VS
    Wingard, JR
    BLOOD, 2002, 100 (11) : 461B - 461B
  • [2] Infectious complications in non-myeloablative conditioning and allogeneic peripheral blood stem cell transplantation for patients with multiple myeloma.
    Lee, CK
    Dignani, C
    Barlogie, B
    Guido, T
    Morris, CL
    Badros, AZ
    Cottler-Fox, MH
    van Rhee, F
    Zanagari, M
    Fassas, A
    Anaissie, EJ
    BLOOD, 2002, 100 (11) : 627A - 627A
  • [3] Unrelated donor hematopoietic cell transplantation after non-myeloablative conditioning for patients with high risk multiple myeloma.
    Sorasio, Roberto
    Giaccone, Luisa
    Patriarca, Francesca
    Montefusco, Vittorio
    Guidi, Stefano
    Busca, Alessandro
    Scime, Rosanna
    Console, Giuseppe
    Milone, Giuseppe
    Marotta, Giuseppe
    Dominietto, Alida
    Rotta, Marcello
    Falda, Michele
    Bacigalupo, Andrea
    Bosi, Alberto
    Corradini, Paolo
    Fanin, Renato
    Pollichieni, Simona
    Bruno, Benedetto
    Boccadoro, Mario
    BLOOD, 2006, 108 (11) : 901A - 901A
  • [4] Non-myeloablative allogeneic transplantation in patients with relapsed or refractory multiple myeloma.
    Gerull, S
    Hegenbart, U
    Goerner, M
    Benner, A
    Moehler, T
    Goldschmidt, H
    Ho, AD
    BLOOD, 2004, 104 (11) : 755A - 755A
  • [5] NON-MYELOABLATIVE CONDITIONING AND ALLOGENEIC TRANSPLANTATION FOR MULTIPLE MYELOMA
    Osman, K.
    Elliott, B.
    Mandeli, J.
    Scigliano, E.
    Ross-Dodds, V.
    Isola, L.
    Grosskreutz, C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 71 - 71
  • [6] Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma
    Osman, Keren
    Elliott, Brian
    Mandeli, John
    Scigliano, Eileen
    Malone, Adriana
    Isola, Luis
    Grosskreutz, Celia
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (04) : 249 - 254
  • [7] Morbidity and mortality with non-myeloablative compared to myeloablative conditioning before stem cell transplantation
    Brychtova, Y.
    Doubek, M.
    Krejci, M.
    Muzik, J.
    Navratil, M.
    Mayer, J.
    Vorlicek, J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S93 - S94
  • [8] Non-myeloablative allogeneic transplantation in patients with high-risk multiple myeloma.
    Gerull, S
    Probst, S
    Ho, AD
    Goldschmidt, H
    Goerner, M
    Schaefer, H
    BLOOD, 2003, 102 (11) : 475B - 475B
  • [9] New non-myeloablative conditioning regimen for multiple sclerosis patients undergoing autologous hematopoietic stem cell transplantation
    Novik, Andrei A.
    Kuznetsov, Alexey N.
    Melnichenko, Vladimir Y.
    Fedorenko, Denis A.
    Ionova, Tatiana L.
    Kruglina, Ruslana V.
    Kartashov, Andrei V.
    Gorodokin, Gary J.
    MULTIPLE SCLEROSIS, 2008, 14 : S169 - S169
  • [10] High-dose melphalan and autologous stem cell transplantation followed by non-myeloablative conditioning regime and allogeneic stem cell transplantation as consolidation therapy in multiple Myeloma.
    Schneider, P
    Fenk, R
    Bernhardt, A
    Rohr, U
    Till, E
    Wehmeier, A
    Haas, R
    Kobbe, G
    BLOOD, 2001, 98 (11) : 351B - 351B
12345